亚托匹性皮肤炎治疗的未来
Katie Lovell1, Nupur Patel1, Saroja Rao1
1Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
Advances in experimental medicine and biology
|May 9, 2024
概括
本综述涵盖了新兴的亚托皮性皮炎 (AD) 治疗方法,包括针对新型白内素的生物药物和新型口服Janus激酶 (JAK) 抑制剂. 它强调了新的局部疗法和正在开发的非常规方法,以改善AD管理.
科学领域:
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 亚托邦性皮肤炎 (AD) 是一种慢性炎症性皮肤疾病,具有显著的未满足需求.
- 目前的治疗方法提供了缓解,但往往有局限性,推动了寻找新疗法的研究.
研究的目的:
- 为了提供一个全面的概述最近的进步在亚托邦性皮炎 (AD) 治疗.
- 专注于目前正在开发中的药物,从早期阶段到FDA批准.
主要方法:
- 关于新兴AD疗法的当前文献的审查.
- 讨论针对特定介质素受体 (IL-31,IL-22,IL-2) 和通路 (OX40-OX40L) 的生物药物.
- 对口服小分子疗法的分析,包括雅努斯激酶 (JAK) 抑制剂,斯芬戈辛-1-酸盐调节剂和布鲁顿氨酸激酶 (BTK) 抑制剂.
- 检查新的局部治疗方法,包括基化酶-4 (PDE4) 抑制剂,tapinarof和针对微生物组的治疗方法.
主要成果:
- 一些针对特定炎症途径的新生物制剂正在开发中.
- 口服小分子抑制剂 (JAK,S1P,BTK) 在全身阿尔茨海默病治疗中表现有前途.
- 新的局部疗法,包括PDE4抑制剂和tapinarof,提供了替代治疗选择.
- 新兴的微生物向和非传统疗法代表了AD管理的未来方向.
结论:
- 亚托皮性皮肤炎治疗的管道是强大的,提供多样化的治疗策略.
- 包括生物药物和小分子在内的向疗法有望显著推进AD管理.
- 未来的研究方向包括微生物组调制和耐火病例的非传统方法.
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
277
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
277
01:19Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
01:19Antiasthma Drugs: Leukotriene Modifiers
281
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
281
01:30Hypersensitivities
615
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
615
01:22iPS Cell Differentiation
2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
239
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
239